in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Biocon and Mylan to Collaborate in Generic Biologics
8:00 AM MDT | July 10, 2009 | Deepti Ramesh
Mylan (Canonsburg, PA) says it has signed an agreement with biotechnology firm Biocon (Bangalore, India) for an exclusive collaboration for the development, manufacturing, and commercialization of multiple, high-value generic biologic compounds for the global market. Mazumdar-Shaw: To lower healthcare costs. The generic pharmaceutical industry, which is based almost entirely on chemically synthesized drugs, is poised for change, Biocon says. Governments worldwide are trying to facilitate the entry of generic biotech or protein derived drugs, in an effort to lower...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee